Online: | |
Visits: | |
Stories: |
Story Views | |
Now: | |
Last Hour: | |
Last 24 Hours: | |
Total: |
RT A group of EpiPen purchasers have hit drug maker Mylan with a class-action lawsuit, claiming the company engaged in illegal price fixing to inflate the price of its allergy treatment over a decade by 574 percent. According to the … Continue reading →
The post Maker of EpiPen hit with fraud & racketeering lawsuit over price-gouging appeared first on From the Trenches World Report.